William Aryitey

My fascination with science, gaming, and writing led to my studying biology at university, while simultaneously working as an online games journalist. After university, I travelled across Europe, working on a novel and developing a game, before finding my way to Texere. As Associate Editor, I’m evolving my loves of science and writing, while continuing to pursue my passion for gaming and creative writing in a personal capacity.

Content by William Aryitey:

Disease Area Analytical science

Real-Time Tumor Analysis

| William Aryitey

MALDI and a SpiderMass device could save valuable surgery time

Disease Area Diagnostics & prognostics

Cost-effective Cancer Checks

| William Aryitey

Testing the whole population of women for breast/ovarian cancers mat be more cost-effective than current methods

Disease Area Cancer

Anticipating NRAS Resistance

| William Aryitey

How researchers are unraveling the mystery of melanoma drug resistance

Research Field Omics

Chemistry Connections

| William Aryitey

Sitting Down With… Carolyn Bertozzi, Anne T. and Robert M. Bass Professor of Chemistry, and Professor (by courtesy) of Chemical & Systems Biology and Radiology,Stanford University, USA.

Disease Area Diagnostics & prognostics

Super Saliva Test

| William Aryitey

Can an oral fluid assay for HIV be as sensitive as a blood test?

Disease Area Drug discovery

Beating the Resistance

| William Aryitey

Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?

Research Field Animal models

Skin in the Game

| William Aryitey

Could donated human skin provide a viable alternative to animal testing?

Outside the Lab Animal models

Pulling Back the Pre-Clinical Curtain

| William Aryitey

Are mouse models the best option we have?

Research Field Immunology

Immune Activation and Autism

| William Aryitey

A genetic pathway behind autism spectrum disorder may have been uncovered

Research Field Cell & gene therapy

Stem Cells for Stroke Recovery

| William Aryitey

A phase II trial shows the safety and efficacy of progenitor cells in stroke victims

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register